Kenjiro Ono et al., 2020, studied the impact of the polyphenolic acids 3-hydroxybenzoic acid (3-HBA), 3,4-dihydroxybenzoic acid (3,4-diHBA), and 3-hydroxyphenylacetic acid (3-HPPA) (derived from gut microbiota-based metabolism of dietary polyphenols) on the brain, and demonstrated their ability to inhibit S oligomerization and mediate aggregate S-induced neurotoxicity in vitro [255]
Been using this for over a year now its fab
That's remarkable
If genetic testing shows predispositions toward lower GLP-1 receptor sensitivity or higher MC4R risk variants, this may suggest you would benefit from closer biomarker monitoring or a more gradual dose escalation to optimize tolerability and results
Compounded semaglutide may differ in efficacy, safety, and outcomes
More importantly, many see improvement in other PCOS symptoms as the weight comes off